Related by context. Frequent words. (Click for all words.) 71 Bovie Medical Corporation 69 Response Biomedical Corporation 69 Ligand Pharmaceuticals Incorporated 69 China Aoxing Pharmaceutical 68 TSX RVX 68 Genaera Corporation 68 EntreMed Inc. 67 Ore Pharmaceuticals 67 Celsion Corporation 67 Nasdaq ENZN 67 Aradigm Corporation 67 NASDAQ LGND 67 Transcept Pharmaceuticals 66 LYON France BUSINESS WIRE 66 Harbor BioSciences 66 Fibrocell Science Inc. 66 Warner Chilcott Limited 66 ACADIA Pharmaceuticals 66 Inc. NASDAQ MRNA 65 AVANIR Pharmaceuticals 65 Connetics Corporation 65 Urigen Pharmaceuticals Inc. 65 Cyclacel Pharmaceuticals 65 Idera Pharmaceuticals 65 Cyclacel Pharmaceuticals Inc. 65 AdvanSource Biomaterials Corporation 65 Metabasis Therapeutics Inc. 65 BioSpecifics Technologies Corp. 65 AVEO Pharmaceuticals Inc. 65 MorphoSys AG FSE MOR 65 SCOLR Pharma Inc. 65 Senesco Technologies 65 Tekmira Pharmaceuticals Corporation 65 Chemokine Therapeutics 65 Immtech Pharmaceuticals Inc. 65 Galapagos NV Euronext GLPG 64 ADVENTRX Pharmaceuticals Inc. 64 Sunesis Pharmaceuticals 64 RONA inc 64 Ambrilia Biopharma Inc. 64 RegeneRx Biopharmaceuticals Inc. 64 Sunesis Pharmaceuticals Inc. 64 IOMED 64 Inc. Nasdaq IMGN 64 ImClone Systems Incorporated 64 Trueclaim Exploration Inc. 64 Barrier Therapeutics Inc. 64 NASDAQ CYPB 64 Emisphere Technologies 64 OncoGenex Pharmaceuticals Inc. 64 Covalon Technologies Ltd. 64 Inc. Nasdaq SEPR 64 Nastech Pharmaceutical Company 64 NASDAQ ARIA 64 Sinobiopharma Inc. 64 TSX AMB 64 Sinobiomed 64 NovaBay Pharmaceuticals Inc. 63 NASDAQ SHPGY 63 Omeros Corporation 63 Manicouagan Minerals Inc. 63 Nektar Therapeutics Nasdaq 63 Pharmion Corporation 63 Hybridon 63 DURECT Corporation 63 eResearchTechnology Inc. 63 Shareholder Letter 63 Healthnostics Inc. 63 Migao Corporation 63 Paladin Labs 63 MiddleBrook Pharmaceuticals Inc. 63 Enzon Pharmaceuticals Inc. 63 Altus Pharmaceuticals 63 NWT Uranium Corp. 63 Alseres Pharmaceuticals Inc. 63 DIAGNOS inc 63 Nasdaq ADLR 63 IMPAX Laboratories Inc. 63 Generex Biotechnology 63 PRNewswire FirstCall Amylin Pharmaceuticals 62 Neoprobe Corporation 62 Cerus Corporation 62 ImmunoGen Inc. 62 Synergy Pharmaceuticals 62 Anika Therapeutics 62 Flamel Technologies 62 Sernova Corp. 62 Joins OTCQX 62 Cardium Therapeutics Inc. 62 Vena Resources Inc. 62 Director Shareholding 62 Gemini Explorations Inc. 62 Adroit Resources Inc. 62 DOES NOT ACCEPT RESPONSIBILITY 62 Biosite Incorporated 62 Inovio Pharmaceuticals 62 Commences Trading 62 Genelabs Technologies Inc. 62 DARA BioSciences 62 Nasdaq XOMA 62 Pluristem Therapeutics